EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease

Josh Landers, Cody Walker, Tyler Skaddy

Journal of Neurology Research · 2026-09 · 16 (3) · 150-157

DOI: 10.14740/jnr1122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neurology Research, 2026-09. Verfasst von Josh Landers und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Landers, J., Walker, C., & Skaddy, T. (2026). Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. Journal of Neurology Research, 16(3), 150-157. https://doi.org/10.14740/jnr1122

Vancouver

Landers J, Walker C, Skaddy T. Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease. Journal of Neurology Research. 2026;16(3):150-157. doi:10.14740/jnr1122

BibTeX
@article{Landers2026,
  author = {Landers, Josh and Walker, Cody and Skaddy, Tyler},
  title = {Telmisartan for Apolipoprotein E ε4 Carriers as a Candidate Precision Medicine Strategy in Alzheimer’s Disease},
  journal = {Journal of Neurology Research},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {150--157},
  doi = {10.14740/jnr1122}
}
Kostenlos starten →